Attached files

file filename
8-K - 8-K BODY - STERICYCLE INCbo8k1212.htm

EXHIBIT 99.1




FOR FURTHER INFORMATION CONTACT:

FOR IMMEDIATE RELEASE


Frank ten Brink  847-607-2012

 

Conference call to be held February 6, 2013 4:00 p.m. Central time – Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available through March 5th by dialing 855-859-2056, access code 86463685. To hear a live simulcast of the call over the internet on www.earnings.com, or to access an audio archive of the call, go to the Investors page on Stericycle’s website at www.stericycle.com.


STERICYCLE, INC. REPORTS RESULTS

FOR FOURTH QUARTER AND FULL YEAR ENDED 2012


Lake Forest, Illinois, February 6, 2013—Stericycle, Inc. (NASDAQ:SRCL), today reported financial results for the fourth quarter and full year of 2012.


Revenues for the quarter ended December 31, 2012 were $503.6 million, up 12.8% from $446.6 million in the fourth quarter last year.  Acquisitions contributed approximately $31.1 million to the current period’s growth in revenues.  Revenues increased 13.3% compared to the prior period when adjusted for unfavorable foreign exchange impacts of $2.3 million.  Gross profit was $227.0 million, up 12.6% from $201.5 million in the fourth quarter last year.  Gross profit as a percent of revenue was 45.1% compared with 45.1% in the fourth quarter of 2011.  


Net income attributable to Stericycle for the fourth quarter of 2012 was $70.1 million or $0.80 per diluted share compared with $64.3 million or $0.74 per diluted share for the fourth quarter of 2011.  Net income attributable to Stericycle for the fourth quarters of 2012 and 2011 includes acquisition expenses, adjustments of contingent consideration to fair value, restructuring and plant closure costs, loss on the sale of business, litigation settlement expense, and other items.  Excluding the effect of these items, non-GAAP earnings per diluted share were $0.88 for the current quarter (see table below).  Non-GAAP earnings per diluted share increased 15.1% from non-GAAP earnings per diluted share of $0.76 in the fourth quarter of 2011.  


FULL YEAR RESULTS

Revenues for the full year 2012 were $1.91 billion, up 14.1% from $1.68 billion in 2011. Acquisitions contributed approximately $140.3 million to the current year’s growth in revenues.  Revenues increased 15.4% compared to the prior year when adjusted for unfavorable foreign exchange impacts of $21.8 million.  Gross profit was $857.3 million, up 12.7% from $760.7 million in 2011.  Gross profit as a percent of revenue was 44.8% compared with 45.4% in 2011.  Earnings per diluted share increased 14.6% to $3.08 in 2012 from $2.69 in 2011.  Non-GAAP earnings per diluted share, when adjusted for various items, increased 15.4% to $3.30 from $2.86 (see table below):





Table to reconcile non-GAAP EPS to GAAP EPS

 

Three months ended December 31,

 

Year ending December 31,

 

 

 

 

Change

 

 

 

 

Change

 

2012

2011

 

$

%

 

2012

2011

 

$

%

GAAP EPS

$0.80

$0.74

 

$0.06

8.2%

 

$3.08

$2.69

 

$0.39

14.6%

Acquisition expenses/

Fair Value

0.02

(0.01)

 

 

 

 

0.10

0.12

 

 

 

Restructuring/ Plant Closure

0.01

0.03

 

 

 

 

0.04

0.04

 

 

 

Loss/ (Gain) on Sale

 

 

 

 

 

 

0.04

0.00

 

 

 

Litigation Expense

0.04

0.01

 

 

 

 

0.04

0.01

 

 

 

Acceleration of Term Loan Fees

 

 

 

 

 

 

0.00

0.01

 

 

 

Non-GAAP EPS (adjusted)

$0.88

$0.76

 

$0.12

15.1%

 

$3.30

$2.86

 

$0.44

15.4%


* In accordance with U.S. generally accepted accounting principles (GAAP), reported earnings per share include the after-tax impact of the items identified in this table. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance. This table and the Company’s internal use of non-GAAP earnings per share are not intended to imply, and should not be interpreted as implying, that non-GAAP earnings per share is a better measure of performance than GAAP earnings per share.


Cash flow from operations was $387.4 million for the full year of 2012.


For more information about Stericycle, please visit our website at www.stericycle.com.


Safe Harbor Statement: Statements in this press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of medical waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.




STERICYCLE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS


In thousands, except share and per share data

 

 

December 31,

 

 

December 31,

 

 

2012

 

 

2011

 

 

(Unaudited)

 

 

(Audited)

ASSETS

 

 

 

 

 

Current Assets:

 

 

 

 

 

     Cash and cash equivalents

$

31,324

 

$

22,511

     Short-term investments

 

503

 

 

416

     Accounts receivable, less allowance for doubtful

         accounts of $19,443 in 2012 and $18,905 in 2011

 

322,246

 

 

290,854

     Deferred income taxes

 

22,995

 

 

19,314

     Prepaid expenses

 

27,042

 

 

22,466

     Other current assets

 

37,176

 

 

35,035

         Total Current Assets

 

441,286

 

 

390,596

Property, Plant and Equipment, net

 

335,870

 

 

293,912

Other Assets:

 

 

 

 

 

     Goodwill

 

2,065,103

 

 

1,913,703

     Intangible assets, less accumulated amortization of

         $64,215 in 2012 and $42,050 in 2011

 

667,471

 

 

546,618

     Other

 

37,008

 

 

32,261

         Total Other Assets

 

2,769,582

 

 

2,492,582

Total Assets

$

3,546,738

 

$

3,177,090

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

     Current portion of long-term debt

$

87,781

 

$

100,526

     Accounts payable

 

74,225

 

 

66,635

     Accrued liabilities

 

135,321

 

 

140,521

     Deferred revenues

 

18,095

 

 

12,855

     Other current liabilities

 

15,638

 

 

6,377

         Total Current Liabilities

 

331,060

 

 

326,914

Long-term debt, net of current portion

 

1,268,303

 

 

1,284,113

Deferred income taxes

 

362,643

 

 

313,733

Other liabilities

 

27,409

 

 

25,079

Equity:

 

 

 

 

 

  

Common stock (par value $.01 per share, 120,000,000

     

authorized, 85,987,883 issued and outstanding in 2012,

    

 and 84,696,227 issued and outstanding in 2011)

 

860

 

 

847

  

Additional paid-in capital

 

116,720

 

 

--

 

Accumulated other comprehensive income

 

(39,064)

 

 

(45,984)

  

Retained earnings

 

1,463,277

 

 

1,243,303

         Total Stericycle, Inc.’s Equity

 

1,541,793

 

 

1,198,166

  

Noncontrolling interest

 

15,530

 

 

29,085

         Total Equity

 

1,557,323

 

 

1,227,251

     Total Liabilities and Equity

$

3,546,738

 

$

3,177,090





STERICYCLE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME


In thousands, except share and per share data

 

Three Months Ended December 31,

 

Year Ended December 31,

 

2012

 

2011

 

2012

 

2011

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

$

% of Rev

 

$

% of Rev

 

$

% of Rev

 

$

% of Rev

Revenues

503,638

100.0

 

446,557

100.0

 

1,913,149

100.0

 

1,676,048

100.0

Cost of revenues

264,541

52.5

 

234,342

52.5

 

1,011,081

52.8

 

874,115

52.2

Depreciation - cost of revenues

12,009

2.4

 

10,697

2.4

 

44,631

2.3

 

41,135

2.5

Restructuring costs

132

0.0

 

--

0.0

 

132

0.0

 

54

0.0

Gross profit

226,956

45.1

 

201,518

45.1

 

857,305

44.8

 

760,744

45.4

Selling, general and administrative expenses

86,496

17.2

 

76,653

17.2

 

327,131

17.1

 

291,468

17.4

Depreciation - SG&A

2,706

0.5

 

2,195

0.5

 

9,598

0.5

 

8,642

0.5

Amortization

6,379

1.3

 

5,167

1.2

 

22,054

1.2

 

16,269

1.0

Total SG&A expense and amortization

95,581

19.0

 

84,015

18.8

 

358,783

18.8

 

316,379

18.9

Income from operations before acquisition, integration, and other expenses

131,375

26.1

 

117,503

26.3

 

498,522

26.1

 

444,365

26.5

Acquisition expenses

1,707

0.3

 

2,310

0.5

 

7,920

0.4

 

16,704

1.0

Restructuring costs and plant closure expense

1,801

0.4

 

3,989

0.9

 

5,201

0.3

 

5,021

0.3

Litigation settlement

6,050

1.2

 

725

0.2

 

6,050

0.3

 

1,185

0.1

Loss/(gain) on sale of assets

--

0.0

 

(304)

-0.1

 

4,867

0.3

 

19

0.0

Change in fair value of contingent consideration

161

0.0

 

(5,081)

-1.1

 

752

0.0

 

(7,221)

-0.4

Integration expenses

1,356

0.3

 

480

0.1

 

4,896

0.3

 

4,346

0.3

Income from operations

120,300

23.9

 

115,384

25.8

 

468,836

24.5

 

424,311

25.3

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

Interest income

71

0.0

 

315

0.1

 

404

0.0

 

799

0.0

Interest expense

(13,077)

-2.6

 

(13,018)

-2.9

 

(51,674)

-2.7

 

(49,431)

-2.9

Other expense,  net

187

0.0

 

(1,696)

-0.4

 

(369)

0.0

 

(3,355)

-0.2

Total other income (expense)

(12,819)

-2.5

 

(14,399)

-3.2

 

(51,639)

-2.7

 

(51,987)

-3.1

Income before income taxes

107,481

21.3

 

100,985

22.6

 

417,197

21.8

 

372,324

22.2

Income tax expense

36,973

7.3

 

35,862

8.0

 

147,256

7.7

 

134,981

8.1

Net income

70,508

14.0

 

65,123

14.6

 

269,941

14.1

 

237,343

14.2

Less: net income attributable to noncontrolling interests

439

0.1

 

835

0.2

 

1,945

0.1

 

2,592

0.2

Net income attributable to Stericycle, Inc.

70,069

13.9

 

64,288

14.4

 

267,996

14.0

 

234,751

14.0

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share-diluted

0.80

 

 

0.74

 

 

3.08

 

 

2.69

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding-diluted

87,281,680

 

 

86,635,383

 

 

87,018,473

 

 

87,367,712

 



STERICYCLE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


In thousands

 

 

Years Ended December 31,

 

 

2012

 

 

2011

 

 

(Unaudited)

 

 

(Audited)

OPERATING ACTIVITIES:

 

 

 

 

 

Net income

$

269,941

 

$

237,343

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Loss on sale of business

 

4,867

 

 

19

Restructuring and plant closure costs

 

1,677

 

 

2,756

Write down of other assets

 

--

 

 

1,256

Change in fair value of contingent consideration

 

752

 

 

(7,221)

Accelerated amortization of term loan financing fees

  

--

 

 

1,241

Stock compensation expense

 

16,339

 

 

15,367

Excess tax benefit of stock options exercised

  

(30,161)

 

 

(17,410)

Depreciation

 

54,229

 

 

49,777

Amortization

 

22,054

 

 

16,269

Deferred income taxes

 

25,541

 

 

31,837

Changes in operating assets and liabilities, net of effect of acquisitions

  and divestitures:

 

 

 

 

 

Accounts receivable

 

(4,329)

 

 

(31,821)

Accounts payable

 

(107)

 

 

(12,539)

Accrued liabilities

 

26,201

 

 

21,656

Deferred revenues

 

931

 

 

(1,997)

Other assets and liabilities

 

(487)

 

 

(429)

     Net cash provided by operating activities

 

387,448

 

 

306,104

 

 

 

 

 

 

INVESTING ACTIVITIES:

 

 

 

 

 

Payments for acquisitions, net of cash acquired

 

(229,684)

 

 

(479,661)

 (Purchases of)/ proceeds from short-term investments

 

(89)

 

 

15,942

Proceeds from sale of business and other assets

 

764

 

 

2,371

Capital expenditures

 

(65,236)

 

 

(53,301)

     Net cash used by investing activities

 

(294,245)

 

 

(514,649)

 

 

 

 

 

 

FINANCING ACTIVITIES:

 

 

 

 

 

Repayment of long-term debt and other obligations

 

(73,766)

 

 

(39,536)

Net (repayments)/ borrowings on senior credit facility

 

(304,309)

 

 

270,827

Proceeds from private placement of long-term note

 

250,000

 

 

--

Payments of deferred financing costs

 

(956)

 

 

(3,740)

Payments on capital lease obligations

 

(3,192)

 

 

(3,333)

Purchase and cancellation of treasury stock

 

(48,028)

 

 

(124,056)

Payments to noncontrolling interests

 

(580)

 

 

(534)

Proceeds from other issuance of common stock

 

64,461

 

 

31,286

Excess tax benefit of stock options exercised

 

30,161

 

 

17,410

     Net cash (used in)/  provided by financing activities

 

(86,209)

 

 

148,324

Effect of exchange rate changes on cash

 

1,819

 

 

3,456

Net  increase/ (decrease) in cash and cash equivalents

 

8,813

 

 

(56,765)

Cash and cash equivalents at beginning of year

 

22,511

 

 

79,276

Cash and cash equivalents at end of year

$

31,324

 

$

22,511

 

 

 

 

 

 

NON-CASH ACTIVITIES:

 

 

 

 

 

Net issuance of obligations for certain acquisitions

$

105,738

 

$

58,338